All Studies

Polyphyllin VII protects from breast cancer-induced osteolysis by suppressing osteoclastogenesis via c-Fos/NFATc1 signaling.

This study explores the potential of Polyphyllin VII (PP7), a compound derived from a traditional Chinese herb, in treating bone destruction caused by metastatic breast cancer. The researchers found that administering PP7 significantly reduced osteolysis induced by breast cancer cells in mice. PP7 also inhibited the formation of osteoclasts, reduced bone resorption, and promoted the formation of osteoblasts. The study suggests that PP7 has the potential to be a safe and effective treatment for preventing and treating bone destruction in breast cancer patients with bone metastases.

Yang Q et al (2023).
Int Immunopharmacol.
PubMed:
37253315

Adaptations in the transformation of cassava (Manihot esculenta Crantz; Euphorbiaceae) for consumption in the dietary management of diabetes: the case of Palikur, or Parikwene People, from French Guiana.

Rapinski M, Cuerrier A and Davy D (2023).
Front Nutr.
PubMed:
37252236